Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are anticipating strong growth driven by the continued https://fraservfbx380449.blogadvize.com/45158596/analyzing-eli-lilly-s-q3-results